Logotype for ASP Isotopes Inc

ASP Isotopes (ASPI) Status Update summary

Event summary combining transcript, slides, and related documents.

Logotype for ASP Isotopes Inc

Status Update summary

23 Nov, 2025

Recent achievements and operational updates

  • Shipped first samples of enriched silicon-28 to a U.S. customer, with commercial production beginning in March 2025.

  • Ytterbium-176 enrichment reached 92.4% in intermediate product; first final product batch expected by end of August 2025, with semi-continuous production delayed to late Q3 or early Q4 2025.

  • Signed a major MOU with Fermi for a joint venture to produce nuclear fuels and enrich strategic isotopes at a Texas energy complex.

  • Listed on the Johannesburg Stock Exchange, with trading commencing August 27, 2025, strengthening ties with South African stakeholders.

  • Carbon-12 and Carbon-14 projects progressing, with Carbon-14 procurement now managed internally and first commercial Carbon-12 product expected in September 2025.

Strategic partnerships and synergies

  • Merger with Renergen aims to create a vertically and horizontally integrated critical materials business, combining helium and isotopic materials for semiconductors and rocketry.

  • Collaboration with Quantum Leap Energy to develop energy isotopes and leverage expertise in fluorination and scale-up technologies.

  • U.S. government engagement includes discussions for grants and loans, with Renergen already securing a $500 million loan for helium supply critical to U.S. national security.

  • Plans to spin out Quantum Leap Enrichment as a standalone public company in 2H 2025, pending approvals.

  • Anticipates closing the Renergen acquisition in Q3 2025, subject to regulatory and third-party consents.

Market and product development

  • Focus on producing isotopes such as HALU, Lithium-6, Lithium-7, silicon-28, and strategic gases for semiconductors at the Fermi site.

  • South African helium is considered strategic due to high concentration, strong U.S.-South Africa relations, and advantageous shipping logistics.

  • Natural gas from Renergen provides a low-cost energy source, supporting competitive production costs for isotope enrichment.

  • Demand for Carbon-12 exceeds Carbon-14, prompting assessment of facility expansion to supply both.

  • Received permits for laser equipment to enrich Nickel-64, Gadolinium-160, and Zinc-68, accelerating facility construction plans.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more